生命科学资讯

IO mulls more layoffs months after halving head count in wake of cancer vaccine setback

Touching base: Beam CEO on gene editing biotech's 'big push' for in vivo delivery

Cancer imaging company buys Lisata for phase 2-stage solid tumor drug

Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat

Polymer Upcycling via Reactive Extrusion: FTIR Microscopy Unlocks Blend Compatibilization Insights - AZoM

#JPM26: Regeneron, Lilly, Summit on rivals crowding into same targets

Exclusive: Claim Health raises $4.4M to help home care providers get paid

Universal Beteiligungs und Servicegesellschaft mbH Sells 9,703 Shares of Agilent Technologies, Inc. $A - MarketBeat

Korean universities patent new PAK4 degradation inducers

Novacell Technology reports new FPR2 agonists

Nippon Zoki Pharmaceutical synthesizes new GABA-A receptor subunit positive allosteric modulators

Novartis discovers new CDK inhibitors

Fosun-funded Hygtia Therapeutics licenses Insilico’s NLRP3 inhibitor for Parkinson’s

Earnings Preview: What to Expect From Agilent Technologies' Report - Barchart.com

Think Bioscience gets $55M to unearth new drug pockets

Cancer R&D is thriving. Here are the areas to watch in 2026.

Forensic Technology Market Is Going to Boom | Agilent Technologies • QIAGEN • Bio-Rad Laboratories • LGC Limited - openPR.com

Allstate Corp Purchases Shares of 9,640 Agilent Technologies, Inc. $A - MarketBeat

10x Genomics Stock (+7.5%): 52-Week High Breakout on Clinical News Flow - Trefis

Worldwide Clinical Trials adds Catalyst Clinical to global CRO mixture